Though new COVID-19 cases are down nearly 20% from last week in the Americas, many countries are experiencing a resurgence in infections, officials from the Pan American Health Organization (PAHO) announced at a press briefing on Wednesday.  Over 962,280 new cases were reported in the region in the past week, according to data from the […] Continue reading ->
Pharmaceutical companies continue to develop COVID-19 vaccine boosters amid condemnation of people in wealthy countries getting additional shots when much of the world is unvaccinated. The US Health and Human Services Department reiterated on Monday that booster shots were not necessary for fully vaccinated Americans after meeting with Pfizer, which is conducting a booster trial. […] Continue reading ->
Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed.  But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading ->
Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading ->
The much-trumpeted European Union COVID Digital Green Pass, which launches 1 July and is meant to vastly ease travel to Europe for vaccinated and recovered passengers is being rolled out with one important hitch. Anyone vaccinated with an AstraZeneca vaccine produced by the Serum Institute of India would not be qualified to get the pass […] Continue reading ->
From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2.   At the same time, […] Continue reading ->